AE
Amal Salah Elhamaky

Publications (4)

Atorvastatin for reduction of 28-day mortality in severe and critical COVID-19 patients: a randomized controlled trial
Article scientifique · 2024
Atorvastatin for Reduction of 28-day Mortality in Sever and Critical COVID-19 Patients: A Randomized Controlled Trial
Article scientifique · 2023
Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial
Article scientifique · 2022
Atorvastatin For Reduction Of 28-Day Mortality In Hospitalized COVID-19 Patients: A Protocol For A Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial
Article scientifique · 2022

Domaines principaux

Sciences de la santé4

Statistiques

Consultations2
Téléchargements0